KDA
WST icon

Kraft Davis & Associates’s West Pharmaceutical WST Stock Holding History

Kraft Davis & Associates’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-695
Closed -$248K – 149
2024
Q1 		$248K Sell
695
-5
-0.7% -$1.85K 0.07% 121
2023
Q4 		$253K Sell
700
-3
-0.4% -$1.06K 0.08% 113
2023
Q3 		$260K Sell
703
-5
-0.7% -$1.93K 0.1% 91
2023
Q2 		$283K Buy
+708
New +$253K 0.1% 94
2022
Q4 		$208K Buy
+758
New +$180K 0.08% 95

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kraft Davis & Associates's WST Position: Q2 2024 in Review

Kraft Davis & Associates sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 695 shares — an estimated $248K sold.

Kraft Davis & Associates first reported a position in WST in Q4 2022 and held it in 5 quarters. The position peaked at $283K in Q2 2023. 777 funds tracked by Wall St. Rank hold WST as of Q2 2024.

  • Kraft Davis & Associates reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Kraft Davis & Associates sold 695 West Pharmaceutical shares in Q2 2024, an estimated $248K.
  • Kraft Davis & Associates first reported a position in West Pharmaceutical in Q4 2022 and held it in 5 quarters.
  • Kraft Davis & Associates's West Pharmaceutical position peaked at $283K in Q2 2023.
  • 777 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on Kraft Davis & Associates's 13F filing for Q2 2024, filed 29 Jul 2024.